Xorte logo

News Markets Groups

USA | Europe | Asia | World| Stocks | Commodities



Add a new RSS channel

 

Keywords

2025-07-02 08:23:02| The Economic Times

Shares of Inox Wind rose nearly 4% after Motilal Oswal initiated coverage with a Buy rating and a target price of Rs 210. The brokerage cited strong order visibility, robust O&M capacity, and vertically integrated operations as key strengths, projecting a 21% upside from current levels and long-term potential in Indias growing wind energy market.


Category: News and Media

 

2025-07-02 08:10:42| The Economic Times

RITES shares surged over 6% to Rs 296 following the announcement of a USD 3.6 million international contract from African Rail Company. This order involves supplying and commissioning two fully overhauled ALCO diesel-electric locomotives for deployment in Zimbabwe, Mozambique, and Botswana. The project, expected to be completed within 9 months, includes warranty support and technical deployment.


Category: News and Media

 

2025-07-02 07:52:59| The Economic Times

Standard Chartered Bank's Steve Englander analyzes market reactions to the potential passage of the Trump tax bill. He notes uncertainty in equities and the dollar. The market anticipates a benign resolution to the tariff deadline. Focus shifts to growth and profits, with AI potentially influencing market tone. The dollar's future is uncertain, influenced by yields and risk premiums.


Category: News and Media

 

2025-07-02 07:45:18| The Economic Times

RBL Bank shares: The stock, which has surged over 21% in the past month and more than 64% in the last six months, extended its winning streak by rising for the eighth time in nine sessions. It closed on Tuesday at Rs 259.95, up 4.6%, with a market capitalization of Rs 15,831.21 crore.


Category: News and Media

 

2025-07-02 07:43:04| The Economic Times

AstraZeneca Pharma India shares saw a rise after Imfinzi got approval for expanded use. The CDSCO approved it as a first-line treatment for specific endometrial cancer cases. This follows AstraZeneca's strong Q4 earnings, with a significant jump in net profit and revenue. The company attributes this to its focus on innovation.


Category: News and Media

 

Sites : [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] next »

Privacy policy . Copyright . Contact form .